Your browser doesn't support javascript.
loading
A phthalimidoalkanamide derived novel DNMT inhibitor enhanced radiosensitivity of A549 cells by inhibition of homologous recombination of DNA damage.
Kang, Hyun-Cheol; Chie, Eui Kyu; Kim, Hak Jae; Kim, Jin Ho; Kim, Il Han; Kim, Kwangsoo; Shin, Beom Su; Ma, EunSook.
Afiliación
  • Kang HC; Department of Radiation Oncology, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.
  • Chie EK; Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.
  • Kim HJ; Department of Radiation Oncology, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.
  • Kim JH; Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.
  • Kim IH; Department of Radiation Oncology, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.
  • Kim K; Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.
  • Shin BS; Department of Radiation Oncology, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.
  • Ma E; Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.
Invest New Drugs ; 37(6): 1158-1165, 2019 12.
Article en En | MEDLINE | ID: mdl-30793218
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ftalimidas / Fármacos Sensibilizantes a Radiaciones / Metilasas de Modificación del ADN Límite: Humans Idioma: En Revista: Invest New Drugs Año: 2019 Tipo del documento: Article País de afiliación: Corea del Sur
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ftalimidas / Fármacos Sensibilizantes a Radiaciones / Metilasas de Modificación del ADN Límite: Humans Idioma: En Revista: Invest New Drugs Año: 2019 Tipo del documento: Article País de afiliación: Corea del Sur